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Abstract The NF-UB transcriptional factor regulates various
functions such as immune responses, cellular growth and devel-
opment, and is frequently activated in tumor cells. Thus, inhi-
bition of NF-UB could suppress tumor cell growth. Using a
decoy synthetic hairpin-shaped oligodeoxyribonucleotide
(ODN) containing the UB site with an integrated single diphos-
phoryldisul¢de linkage, we demonstrate its covalent binding to
the p50 subunit of NF-UB. Furthermore, this decoy ODN in-
duces apoptosis in a lymphoblastoma cell line. Thus, such
chemically modi¢ed decoys could be valuable tools for blocking
nuclear factors and tumor cell growth.
) 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
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1. Introduction
The transcription factor decoys (TFDs) are modi¢ed syn-
thetic DNA molecules which block binding of transcription
factors to the target gene by mimicking the speci¢c DNA
binding sites. Such decoys are e⁄cient and speci¢c inhibitors
of transcription. For instance, decoy oligodeoxyribonucleoti-
des (ODNs) of the transcription factors E2F, NF-UB, CREB
or AP-1 have been shown to e⁄ciently cure vascular prolifer-
ation [1], myocardial infarction [2], or to prevent tumor
growth and invasiveness [3,4]. Initially shown to be implicated
in host defense and in£ammatory response [5], NF-UB is as-
sociated with induction of apoptosis in some cells but it is also
involved in protection against apoptosis in Epstein^Barr virus
(EBV)-transformed B cells [6]. EBV can induce the prolifer-
ation of resting B cells in vitro yielding immortalized cell lines.
In these cell lines the viral protein latent membrane protein-1
induces NF-UB by mimicking a constitutively active receptor
of the tumor necrosis factor receptor family [7], and the spe-
ci¢c inhibition of NF-UB promotes apoptosis [8,9] demon-
strating its fundamental role. Chemical modi¢cations of de-
¢ned positions in a DNA probe have been previously shown
to allow crosslinking of the corresponding DNA binding re-
gion of the transcription factor. Sets of DNA or RNA du-
plexes with chemically active internucleotide linkages were
successfully used for a⁄nity modi¢cation and probing the
nucleic acid binding regions of restriction^modi¢cation en-
zymes [10], of RNA recognizing TAT peptide [11] and of
transcription factors [12]. Recently, a new class of reactive
double-stranded (ds) DNA derivatives which can crosslink
with proteins recognizing speci¢c nucleic acid sequences was
investigated [13]. In this study we analyzed a new hairpin-
shaped modi¢ed TFD comprising a NF-UB binding sequence
and an integrated diphosphoryldisul¢de linkage replacing the
native phosphodiester bond (Fig. 1A). According to our pre-
vious data [13], this modi¢cation can react with nearby cys-
teine residues by a thiol^disul¢de exchange reaction within the
speci¢c dsDNA^protein complex. Indeed, X-ray analysis of
the NF-UB^DNA complex has shown that the cysteine 59 is
located at a distance of 3.98 AC from the internucleotide phos-
phate group that we chose to chemically modify [14]. This
proximity allows covalent entrapment of the decoy ODN
with the NF-UB p50 subunit. The new hairpin decoy ODN
thus synthesized was shown to e⁄ciently bind the NF-UB p50
subunit and to inhibit cell growth and induce apoptosis in a
lymphoblastoid cell line (LCL).
2. Materials and methods
2.1. Synthesis of the NF-UB decoy oligonucleotide
Oligonucleotides with 3P- and 5P-phosphorothioate groups used for
preparing the hairpin-shaped decoy, 5P-TGGGAATT-3P-OP(NO)-
(OH)(SH) (1) and 5P-(HS)(HO)P(NO)O-CCCCTCGAAGAGGG-
GAATTCCCA (2), and the scramble control, 5P-CAGTCACTACG-
CAAAGCGTAG-3P-OP(NO)(OH)(SH) (3) and 5P-(HS)(HO)P(NO)-
O-TGACTGCACGGT (4), were prepared as described [13]. They
were kept in boiled water under argon to avoid their oxidation to
disul¢de-linked dimers by solved oxygen. The oligonucleotide 5P-phos-
phorothioate (2) was converted in 95% yield to the 2-pyridyldisul¢de
derivative by treatment with 0.03 M 2,2P-dipyridyldisul¢de in bu¡er
1 pH 4.5^5 (0.015 M Na-citrate, 0.15 M NaCl, 0.02 M MgCl2), 50%
dimethylformamide for 40 min at room temperature and was isolated
from the reaction mixture by ethanol precipitation. The other duplex-
forming component (1) was then added with a 1.3 molar excess to the
2-pyridyldisul¢de derivative in bu¡er 1 for 40 min at room temper-
ature. The decoy hairpin ODN was isolated from the reaction mixture
by ethanol precipitation and analyzed on 20% polyacrylamide, 7 M
urea denaturing gel electrophoresis. The reaction product was ex-
tracted from gel slices with 10 mM Tris^HCl, pH 7.6, 0.3 M NaCl,
1 mM EDTA overnight at room temperature and isolated by ethanol
precipitation.
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2.2. Cell culture and cell transfection
The EBV-transformed lymphoblastoid cell line LCL (Priess) was
grown in RPMI 1640 (Eurobio, Les Ulis, France) supplemented
with 10% decomplemented fetal calf serum (Invitrogen, Cergy Pon-
toise, France), 100 U/ml penicillin, 10 Wg/ml streptomycin, 2 mM
L-glutamine at 37‡C in a humidi¢ed 5% CO2 atmosphere. For trans-
fection, 5U106 cells were resuspended in RPMI without fetal calf
serum and electroporated with the decoy ODN or the scrambled
ODN at 250 V and 960 WF (Bio-Rad, Vitry/Seine, France). In some
experiments daunorubicin (Cerubidine 20 mg, Rho“ne Poulenc, Lyon,
France) was added at 0.25 WM 5 h after transfection.
2.3. Western blotting
The cells were washed twice in phosphate-bu¡ered saline, counted
and lysed in 2Usodium dodecyl sulfate (SDS) sample bu¡er (Bio-
Rad) followed by brief sonication to break the DNA. The samples
were separated on SDS^polyacrylamide gels (8 and 10%) and trans-
ferred onto nitrocellulose membranes (Schleicher and Schuell, Dassel,
Germany). Following transfer, the membranes were stained in Pon-
ceau red to verify equal protein loading. The membranes were then
washed in water for 30 min and incubated for 2 h with Tris-bu¡ered
saline (10 mM Tris, pH 8, 30 mM NaCl, TBS) supplemented with
dried skimmed milk (3%). Speci¢c antibodies were added for 2 h.
After three washes of 30 min each with TBS, the secondary antibodies
conjugated with horseradish peroxidase (1:5000 in TBS) were added
for 1 h, followed by another three washes of 30 min in TBS. Bands
were visualized on X-Omat R ¢lms (Kodak, Rochester, NY, USA) by
enhanced chemiluminescence following the supplier’s procedure
(Amersham Biosciences, Saclay, France). The antibodies against hu-
man p50 subunit (rabbit immune serum #1157) used for Western
blotting (1:2000), immunoprecipitation (1:30) (rabbit immune serum
#1141) and supershifts were a generous gift of Dr. N. Rice (NCI,
Frederick, MD, USA). The cleaved poly(ADP-ribose) polymerase
(PARP) (Asp214) human speci¢c antibody (Cell Signaling, Beverly,
MA, USA) was diluted at 1:1000.
2.4. Electrophoretic migration shift assay (EMSA)
Two oligonucleotides, 5P-AGTTGAGGGGACTTTCCCAGGC
and 5P-GCCTGGGAAAGTCCCCTCAACT (Proligo, France), were
annealed to give a control NF-UB probe. Nuclear extracts were pre-
pared as described [15]. Total proteins were assayed using the Brad-
ford procedure (Bio-Rad). The control NF-UB probe, scrambled
ODN and TFD (100 ng) were labeled at the 3P end using terminal
deoxynucleotidyl transferase (MBI, Euromedex, Mundolsheim,
France). 32P-labeled ODNs were puri¢ed on a column (Qiaquick re-
moval nucleotide kit, Qiagen, Courtaboeuf, France). The DNA bind-
ing reaction mixture contained: 20 Wg of nuclear extract and 3^10 ng
of 32P-labeled ODN. The reaction was performed in a ¢nal volume of
30 Wl in a bu¡er containing 20 mM HEPES, 20% glycerol v/v, 0.1 M
KCl, 0.2 mM EDTA and 714 Wg/ml of salmon sperm DNA (Sigma-
Aldrich, Saint Quentin Falavier, France). For competition a 100-fold
excess of the non-radiolabeled competitor ODN was added to the
sample before addition of the 32P-labeled ODN. To identify the pro-
teins, antibodies to NF-UB p50 subunit at 1/10 of the ¢nal volume
were added to the mixture. The samples were analyzed on a 6% non-
denaturing polyacrylamide gel run at 150 V for 4 h. The gels were
dried and exposed on a phosphor storage screen (Packard, BD,
France).
2.5. Covalent binding assay
Nuclear extracts were incubated with the radiolabeled ODN over-
night at 4‡C. In some experiments 2-mercaptoethanol was added (5, 6
or 10 WM) for 1 h at 37‡C, before or after binding. The samples were
loaded on SDS^polyacrylamide gel (8%). After electrophoresis and
Western blotting, the dried nitrocellulose membranes were exposed
Fig. 1. Binding of the NF-UB decoy ODN to NF-UB detected by
EMSA. A: Sequence of the modi¢ed hairpin decoy ODN showing
the position of the diphosphoryldisul¢de link (the UB binding site is
underlined). B: Binding of 32P-labeled oligonucleotide probes con-
taining UB sites to the p50 subunit of NF-UB from LCL nuclear ex-
tracts. EMSA for scrambled ODN (lanes 1 and 2), decoy ODN
(lanes 3 and 4), and control NF-UB probe (lanes 5 and 6) in the ab-
sence (3) or in the presence (+) of p50 antibody. The NF-UB^ODN
complex (NF) and supershifts (SS) are indicated by white and black
arrowheads respectively. C: Competition experiments: lane 1: excess
(100U) unlabeled UB probe; lane 2: excess (100U) decoy ODN;
lane 3: excess (100U) scrambled ODN; lane 4: UB probe.
Fig. 2. Demonstration of a covalent bond between the decoy ODN
and the p50 subunit of NF-UB. A: Nuclear extracts from LCL cells
were incubated with radiolabeled decoy ODN. Western blotting was
performed directly from extracts (lane 1) or following immunopre-
cipitation with anti-p50 antibody (lane 2). The same nitrocellulose
membrane was revealed for radioactivity of direct extract (lane 3)
or following immunoprecipitation (lane 4). Radioactive ink (5000
cpm) was spotted on membranes to indicate molecular weights and
as a standard. B: Controls : a radiolabeled control scrambled ODN
was incubated with nuclear extract (lanes 1 and 3) and the decoy
ODN was incubated with bovine serum albumin instead of nuclear
extract (lanes 2 and 4).
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on phosphor storage screen, radioactive intensities were determined
using the screen system controlling software (Packard, BD). After
exposure, membranes were blocked and processed as above.
3. Results
The binding of the decoy ODN to NF-UB was analyzed by
EMSA with nuclear extracts from LCL in which NF-UB is
known to be activated [8]. The results (Fig. 1B) show that the
decoy ODN binds a component which comigrates with NF-
UB. To identify the protein bound to the radiolabeled decoy
ODN, supershifts were performed with antibody to the NF-
UB p50 subunit. The supershift observed with the decoy ODN
was similar to that observed using the control NF-UB probe
(Fig. 1B), thus demonstrating speci¢c binding to the p50 sub-
unit of NF-UB. No speci¢c binding was observed with the
modi¢ed scrambled ODN, moreover, competition with an ex-
cess of unlabeled decoy ODN prevented binding of the labeled
p50 NF-UB probe (Fig. 1C) demonstrating that the NF-UB
decoy binds speci¢cally to the NF-UB p50 subunit. To show
that the decoy binds through a covalent bond, the nuclear
extracts were incubated with the decoy ODN then treated
with SDS and analyzed by SDS^polyacrylamide gel electro-
phoresis and Western blotting. After transfer, a radioactive
band migrated at the same level as the NF-UB p50 subunit
and was revealed on the same membrane with a speci¢c anti-
body (Fig. 2A). Nuclear extract incubated with the decoy
ODN and immunoprecipitated with anti-p50 antibody re-
vealed a radioactive 50 kDa band. No binding was detected
using either bovine serum albumin or a control scrambled
ODN containing the same chemical modi¢cation as the decoy
ODN (Fig. 2B). Since the covalent bond between the decoy
ODN and NF-UB must be a disul¢de bond, we treated the
crosslinked complex with 2-mercaptoethanol after binding,
releasing over 50% of the radioactivity (Fig. 3A). Moreover,
addition of the 2-mercaptoethanol before binding completely
prevented crosslinking of the modi¢ed decoy (Fig. 3B). Alto-
gether, these observations demonstrate that the decoy ODN
binds the p50 subunit of NF-UB through a covalent disul¢de
bond. As NF-UB has been reported to protect cells from ap-
optosis in the LCL [8,9] we examined whether the decoy af-
fected cell proliferation or apoptosis. Cells were transfected
with the decoy ODN and also treated with daunorubicin, a
DNA-intercalating chemotoxic drug known to induce apopto-
sis. Twenty-four hours after transfection with the decoy
ODN, cell proliferation was reduced (Fig. 4A) with an ampli-
tude equivalent to that observed with daunorubicin-treated
cells. This e¡ect was enhanced when cells were treated with
daunorubicin and the decoy ODN. Transfection of the
scrambled ODN did not a¡ect cell proliferation. Apoptosis
in the cells transfected with the decoy ODN was analyzed
using an antibody raised against the cleaved form of PARP
[16]. As little as 0.1 Wg of the ODN decoy was su⁄cient to
Fig. 3. The bond between the p50 subunit of NF-UB and the decoy
ODN is cleaved by 2-mercaptoethanol. A: After binding of the ra-
diolabeled decoy ODN, nuclear extracts were incubated with no
(lane 3), 5 WM (lane 2) or 10 WM (lane 1) of 2-mercaptoethanol
(2 ME). After gel separation, Western blotting was performed with
p50 antibody following which the same membrane was analyzed for
radioactivity. Histograms indicate the intensities of the radioactive
bands detected. B: The crosslinking between the radiolabeled decoy
ODN and the NF-UB p50 subunit is completely prevented by 2-mer-
captoethanol. Cell nuclear extracts were incubated with 2-mercapto-
ethanol before addition of decoy ODN (lane 1) or control
scrambled ODN (lane 2). Western blotting was performed with p50
antibody. The decoy ODN was incubated with bovine serum albu-
min instead of nuclear extract (lane 3).
Fig. 4. E¡ects of the decoy ODN on cell growth and apoptosis.
A: Inhibition of the proliferation of LCL cells transfected with de-
coy ODN (1 Wg) or scrambled ODN (1 Wg) with or without dauno-
rubicin. Cell proliferation was expressed as a percentage of the level
obtained with control electroporated cells. B: Induction of cell apo-
ptosis by decoy ODN as determined by measuring PARP cleavage.
LCL cells transfected with 1 Wg (lane 4) and 0.1 Wg (lane 5) decoy
ODN. Control electroporated cells (lane 2). Cells transfected with
1 Wg of control scrambled ODN (lane 3). Burkitt’s lymphoma cell
line BL2 as a cleaved PARP control (lane 1).
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induce apoptosis in the LCL and this was increased with 1 Wg
of decoy ODN (Fig. 4B). Cleavage of PARP was not detected
in control electroporated cells or in cells electroporated with
control scrambled ODN, although it contained the reactive
linkage designed to speci¢cally bind NF-UB. Burkitt’s lym-
phoma cells showing a high level of spontaneous apoptosis
were used as a PARP cleavage control. Altogether these re-
sults suggested that the modi¢ed NF-UB decoy ODN reduces
the growth and induces apoptosis in cells.
4. Discussion
The aim of this work was to determine the speci¢city of a
chemically modi¢ed decoy ODN towards its target, and ana-
lyze its e¡ect in cells. Based on X-ray analysis [14], the modi-
¢ed moiety was introduced at a selected position of the decoy
ODN to permit covalent bond formation with NF-UB p50.
Using nuclear cell extracts which represent a complex mix-
ture of hundreds of DNA binding proteins, we demonstrated
that the decoy ODN binds only to the NF-UB p50 subunit.
Our EMSAs and supershifts show identical migration charac-
teristics of the control NF-UB probe and the decoy ODN. We
further veri¢ed that the decoy ODN binds the p50 subunit
covalently, and found that the decoy ODN and the p50 comi-
grate following SDS treatment and that the bond is reversed
by 2-mercaptoethanol thereby demonstrating that it is a di-
sul¢de bond.
Crystallographic studies have shown that the p65 subunit
can also interact via a cysteine residue with a phosphate group
of the UB binding site [14] suggesting that the decoy ODN
could bind the p65. However, in our experiments we did not
detect any binding of the decoy ODN with the p65 subunit.
As only p50 hetero- or homodimers bind DNA, the crosslink-
ing of the decoy ODN may reduce the amount of NF-UB
dimers consisting mostly of p65/p50 heterodimers [17], thereby
resulting in a dominant negative e¡ect. Since inhibition of
NF-UB in the LCL induces apoptosis [8], the enhanced apo-
ptosis and reduced cell growth of LCL cells can be attributed
to the blocking of NF-UB dimers by the binding of the decoy
ODN.
Overall, the present study demonstrates that a chemically
modi¢ed decoy can speci¢cally and covalently bind the NF-
UB p50 subunit, induce apoptosis and slow down cell growth.
Such a decoy may have therapeutic applications and the tech-
nical approach of covalent blocking could also apply to other
DNA binding factors.
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